Thomas Harrison, Professor of Infectious Diseases at St George’s, University of London, is a dedicated, extraordinarily successful clinical academic defining new problems and leading clinical trials which impact the treatment of millions of patients.
His studies on treatment of Cryptococcus have completely revolutionized WHO guidance and changed international clinical practice. He is a world authority on fungal disease and a key contributor to the main international guidelines. He is well recognized for a series of pivotal studies that have altered international practice in tuberculosis management and his input resulted in St. George's being first in the UK for the number of NIHR-approved Covid-19 trials.